Zantac / Ranitidine (NDMA Cancer) Lawsuit in Arkansas

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Arkansas imposes a 3-year statute of limitations for personal injury claims (Ark. Code Ann. § 16-56-105). The discovery rule applies in pharmaceutical injury cases. Arkansas courts apply Daubert under Ark. R. Evid. 702. The 3-year SOL gives claimants with 2023+ cancer diagnoses additional time, but prompt consultation is still essential.

3 years from date of cancer diagnosis discovery (Daubert expert standard)

Arkansas Data

Exposure in Arkansas

Source: U.S. Census Bureau 2024

Source: Ark. Code Ann. § 16-56-105

Medical Resources

Clinics & Specialists in Arkansas

Winthrop P. Rockefeller Cancer Institute (UAMS)

Baptist Health Medical Center Cancer Care

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview